Long
SNCA has broken out of a descending channel
Catalyst Seneca Biopharma, Inc. (Nasdaq: SNCA) entered into a agreement with a privately held company Leading BioSciences, Inc. (“LBS” for a merger with to form Palisade Bio, Inc.
SNCA has broken out of a descending channel and retested the upper trend line.
The idea is self explanatory targets and stop loss is marked on the chart.
A good risk management is key to success in the financial markets. Risk only a small portion of your portfolio in this risky but potential trade.
Note
First price target done.Order cancelled
Reason for cancel is SNCA ticker will be no more after today becasue of a new ticker PALI as the merger comes into effect.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.